NASDAQ:XBIO 8 October 2025

Xenetic Biosciences (XBIO) Stock Skyrockets – Is the Biotech’s 2025 Rally for Real?

Xenetic Biosciences shares surged over 160% intraday on October 8, 2025, closing up 123% at $9.58, with no new company news reported. Trading volume topped 30 million shares despite a public float of just 1.3 million. Analysts cited speculative trading and short covering as likely drivers. Recent clinical updates were last announced in July.

8 October 2025

Biotechnology·NASDAQ:XBIO·Stock Market

Pembroke VCT Boosts Capital with B Share Allotment as Market Liquidity Rises
April 4, 2026, 7:59 AM EDT. Pembroke VCT plc, a UK-listed venture capital trust, has allotted 5.18 million new B Ordinary Shares, raising fresh capital for its high-growth portfolio. The shares, priced at 100.2p based on unaudited net asset value as of December 2025, will trade on the London Stock Exchange around April 9, 2026. This move increases total B shares to nearly 299 million, enhancing market liquidity. The company's diversified venture investments benefit from this capital injection amid persistent negative free cash flow and volatile results. Analyst consensus holds a 'Hold' rating with a £94 price target. Pembroke VCT operates under the UK's FCA rules, targeting smaller, growth-oriented firms and providing investors tax advantages linked to venture capital trusts (VCTs).